Funding profile · Women’s health care delivery
Almond ObGyn
One SEC filing, one round: a $7.2 million seed sold to 42 investors in November 2022. The company closed its clinic in March 2026, with no later filing on record and no reported acquisition or asset sale.
Data as of September 25, 2026. Company-reported figures are labeled.
Rounds at a glance
| When | Round | Amount | Investors | Source |
|---|---|---|---|---|
| Aug 2022 | Y Combinator, Summer 2022 | Not disclosed | Y Combinator | Indep. |
| By Nov 9, 2022 | Seed | $7,198,993 sold of $7,203,992 offered; reported to press as “$7 million” | True Ventures (Tony Conrad) lead; Offline Ventures (Brit Morin); YC group partner Surbhi Sarna named as an investor in one interview | Form D |
| Sep 2024 | No new round reported | Los Angeles Business Journal cites the same “$7 million in venture funding” figure, two years later | Company “declined to name the funders,” per that report | Indep. |
What the filings show
Almond Life, Inc. · Form D · filed Nov 23, 2022
- First sale
- Nov 9, 2022
- Offered
- $7,203,992 equity
- Sold
- $7,198,993 · $4,999 remaining
- Investors
- 42 · average about $171,400
- Exemption
- Rule 506(b)
- Related persons
- Tara Raffi (executive officer, director, promoter); Carly Allen (co-founder, signer)
- Filing
- SEC EDGAR, CIK 0001955200
Reading the filings
- The checks are broad and mid-size, not a few large institutional lines.Forty-two investors split $7,198,993, about $171,400 each. That is consistent with a syndicate of a lead fund, a co-investing fund and a wide angel base, not a two-check institutional round.
- The filing sold almost exactly what it offered.Of $7,203,992 offered, only $4,999 was left unsold at the filing date, essentially a fully subscribed round. The sold amount, $7,198,993, rounds to the “$7 million” figure Almond gave TechCrunch and Femtech Insider the same month.
- The filing does not name a single investor.Item 3 lists only Tara Raffi and Carly Allen, the company’s own founders, as related persons. Every investor name attached to this round, True Ventures, Offline Ventures, Tony Conrad, Brit Morin, Surbhi Sarna, comes from press coverage and a founder interview, not from the SEC filing itself.
- The company’s own disclosure got less specific over time, not more.TechCrunch and Femtech Insider named True Ventures as lead in November 2022, and Forbes added Offline Ventures in August 2024. A Los Angeles Business Journal article from the following month, citing the same $7 million total, said the company “declined to name the funders.”
- Only one Form D exists for this company.No amendment and no later new notice appear under CIK 0001955200. If Almond raised a bridge or a later round before it closed, either it was small enough or structured to avoid a Regulation D filing, or it never closed. No later round was ever announced in the press either.
Commercial signals
| Signal | Detail | Source type |
|---|---|---|
| Early traction | Company said it reached a $90,000 monthly run rate and was booked three weeks out before its first clinic opened, Aug 2022. | Company-stated |
| Pricing evolution | Annual membership was $250 at 2022 launch ($150 for founding members); by Sep 2024 the Los Angeles Business Journal reported a $425 annual gynecology fee and a new $2,500 flat fee group pregnancy program. | Independent |
| Press recognition | Forbes profile, Aug 2024, calling Almond the first full-service, tech-enabled OB-GYN in the country; Raffi and Allen named to Inc.’s 2024 Female Founders 250 list. | Independent |
| New service lines | Group pregnancy care (Oct 2024) and a 35-plus lab diagnostic product called Baseline (by Jan 2025). | Company-stated |
| Closure | Company letter posted early 2026 set Mar 20, 2026 as the last day for most appointments; Yelp and MapQuest list the clinic as permanently closed. No later SEC filing, and no reported sale of assets or acquisition. | Company-stated |
What to watch
- Whether a later Form D, an amendment, or any SEC filing recording a wind-down ever appears under CIK 0001955200; none has as of September 2026.
- Whether any of the named investors, True Ventures or Offline Ventures, comment publicly on the outcome.
- Whether independent financial reporting on the closure, beyond the company’s own letter and directory listings marking it closed, appears.
The Almond ObGyn story on Healthcare DiscoveryHealthcare Discovery
Related companies
Sources
- Public recordForm D, Almond Life, Inc., CIK 0001955200
- IndependentAlmond launches full-service OB-GYN care to rebuild patient experience
- IndependentY-Combinator Alum Almond Raises $7M to Pursue Its Vision of Holistic OB/GYN Care
- IndependentMeet Almond. The First Full-Service, Tech-Enabled OB-GYN In The Country
- IndependentOBGYN Startup Gets Into Group Pregnancy Care
- InterviewBreaking Barriers in Women’s Healthcare with Almond ObGyn
- IndependentAlmond ObGyn, Los Angeles, listing marked permanently closed
- IndependentAlmond ObGyn, 8274 Melrose Ave, listing marked permanently closed
- CompanyAlmond ObGyn closure letter and FAQ
- CompanyAlmond: We make it easy to get great ObGyn care, launch post
Compiled from SEC and other public records and published reports as of September 25, 2026. Form D notices report offerings under Regulation D; amounts reflect the filing date and may not capture later sales or dispositions. Healthcare Venture Capital Fund holds no position in Almond ObGyn. This page is not an offer to sell or a recommendation to buy any security.
